Trial Outcomes & Findings for Diet and Physical Activity Intervention for the Prevention of ADT-Induced Metabolic Changes in Patients With Prostate Cancer, TRIPLE-A PILOT Study (NCT NCT04870515)

NCT ID: NCT04870515

Last Updated: 2026-01-09

Results Overview

Change in body weight from baseline.

Recruitment status

COMPLETED

Study phase

NA

Target enrollment

20 participants

Primary outcome timeframe

0 months, 6 months

Results posted on

2026-01-09

Participant Flow

Participant milestones

Participant milestones
Measure
Group I (Diet, Physical Activity)
Patients attend 10 in-person or virtual sessions with a registered dietitian over 6 months to receive instruction on following a healthy diet pattern. Patients also attend 2 one-on-one sessions with an exercise psychologist to receive instruction on aerobic physical activity and strength/resistance training. Patients may also complete up to 21 additional supervised exercise sessions. Dietary Intervention: Receive dietary instructions Exercise Intervention: Complete aerobic and strength/resistance exercises Quality-of-Life Assessment: Ancillary studies Questionnaire Administration: Ancillary studies
Group II (Standard Lifestyle Recommendations)
Patients receive standard lifestyle recommendations and attend a single individual session with a dietitian to review the US dietary guidelines, activity goal of 30 minutes of physical activity 5 days/week.
Overall Study
STARTED
9
11
Overall Study
COMPLETED
7
8
Overall Study
NOT COMPLETED
2
3

Reasons for withdrawal

Reasons for withdrawal
Measure
Group I (Diet, Physical Activity)
Patients attend 10 in-person or virtual sessions with a registered dietitian over 6 months to receive instruction on following a healthy diet pattern. Patients also attend 2 one-on-one sessions with an exercise psychologist to receive instruction on aerobic physical activity and strength/resistance training. Patients may also complete up to 21 additional supervised exercise sessions. Dietary Intervention: Receive dietary instructions Exercise Intervention: Complete aerobic and strength/resistance exercises Quality-of-Life Assessment: Ancillary studies Questionnaire Administration: Ancillary studies
Group II (Standard Lifestyle Recommendations)
Patients receive standard lifestyle recommendations and attend a single individual session with a dietitian to review the US dietary guidelines, activity goal of 30 minutes of physical activity 5 days/week.
Overall Study
Lost to Follow-up
0
2
Overall Study
Withdrawal by Subject
0
1
Overall Study
Withdrawal due to complications with standard of care treatment
2
0

Baseline Characteristics

Diet and Physical Activity Intervention for the Prevention of ADT-Induced Metabolic Changes in Patients With Prostate Cancer, TRIPLE-A PILOT Study

Baseline characteristics by cohort

Baseline characteristics by cohort
Measure
Group I (Diet, Physical Activity)
n=9 Participants
Patients attend 10 in-person or virtual sessions with a registered dietician over 6 months to receive diet instructions. Patients also attend 2 one-on-one sessions with an exercise psychologist to receive instruction to complete aerobic physical activity and strength/resistance training. Patients may also complete up to 21 additional supervised exercise sessions. Dietary Intervention: Receive dietary instructions Exercise Intervention: Complete aerobic and strength/resistance exercises Quality-of-Life Assessment: Ancillary studies Questionnaire Administration: Ancillary studies
Group II (Standard Lifestyle Recommendations)
n=11 Participants
Patients receive standard lifestyle recommendations and attend an individual session with a dietitian over 20-30 minutes including US dietary guidelines, activity goal of 30 minutes of physical activity 5 days/week; and discussion of the health benefits of weight loss along with general behavior change suggestions for weight loss. Best Practice: Receive standard lifestyle recommendations Quality-of-Life Assessment: Ancillary studies Questionnaire Administration: Ancillary studies
Total
n=20 Participants
Total of all reporting groups
Age, Categorical
<=18 years
0 Participants
n=9 Participants
0 Participants
n=6 Participants
0 Participants
n=9 Participants
Age, Categorical
Between 18 and 65 years
2 Participants
n=9 Participants
0 Participants
n=6 Participants
2 Participants
n=9 Participants
Age, Categorical
>=65 years
7 Participants
n=9 Participants
11 Participants
n=6 Participants
18 Participants
n=9 Participants
Age, Continuous
71.0 years
STANDARD_DEVIATION 5.7 • n=9 Participants
73.6 years
STANDARD_DEVIATION 4.5 • n=6 Participants
72.43 years
STANDARD_DEVIATION 5.12 • n=9 Participants
Sex: Female, Male
Female
0 Participants
n=9 Participants
0 Participants
n=6 Participants
0 Participants
n=9 Participants
Sex: Female, Male
Male
9 Participants
n=9 Participants
11 Participants
n=6 Participants
20 Participants
n=9 Participants
Ethnicity (NIH/OMB)
Hispanic or Latino
1 Participants
n=9 Participants
0 Participants
n=6 Participants
1 Participants
n=9 Participants
Ethnicity (NIH/OMB)
Not Hispanic or Latino
8 Participants
n=9 Participants
11 Participants
n=6 Participants
19 Participants
n=9 Participants
Ethnicity (NIH/OMB)
Unknown or Not Reported
0 Participants
n=9 Participants
0 Participants
n=6 Participants
0 Participants
n=9 Participants
Race (NIH/OMB)
American Indian or Alaska Native
0 Participants
n=9 Participants
0 Participants
n=6 Participants
0 Participants
n=9 Participants
Race (NIH/OMB)
Asian
0 Participants
n=9 Participants
0 Participants
n=6 Participants
0 Participants
n=9 Participants
Race (NIH/OMB)
Native Hawaiian or Other Pacific Islander
0 Participants
n=9 Participants
0 Participants
n=6 Participants
0 Participants
n=9 Participants
Race (NIH/OMB)
Black or African American
0 Participants
n=9 Participants
0 Participants
n=6 Participants
0 Participants
n=9 Participants
Race (NIH/OMB)
White
9 Participants
n=9 Participants
11 Participants
n=6 Participants
20 Participants
n=9 Participants
Race (NIH/OMB)
More than one race
0 Participants
n=9 Participants
0 Participants
n=6 Participants
0 Participants
n=9 Participants
Race (NIH/OMB)
Unknown or Not Reported
0 Participants
n=9 Participants
0 Participants
n=6 Participants
0 Participants
n=9 Participants
Region of Enrollment
United States
9 participants
n=9 Participants
11 participants
n=6 Participants
20 participants
n=9 Participants

PRIMARY outcome

Timeframe: 0 months, 6 months

Data is reported as a percentage change in Homeostatic Model Assessment of Insulin Resistance (HOMA-IR) score from baseline. HOMA-IR is an index to estimate the insulin resistance of a patient. HOMA-IR is defined as (glucose (mg/dl) insulin (uIU/ml)) / 405.

Outcome measures

Outcome measures
Measure
Group I (Diet, Physical Activity)
n=7 Participants
Patients attend 10 in-person or virtual sessions with a registered dietician over 6 months to receive diet instructions. Patients also attend 2 one-on-one sessions with an exercise psychologist to receive instruction to complete aerobic physical activity and strength/resistance training. Patients may also complete up to 21 additional supervised exercise sessions. Dietary Intervention: Receive dietary instructions Exercise Intervention: Complete aerobic and strength/resistance exercises Quality-of-Life Assessment: Ancillary studies Questionnaire Administration: Ancillary studies
Group II (Standard Lifestyle Recommendations)
n=8 Participants
Patients receive standard lifestyle recommendations and attend an individual session with a dietitian over 20-30 minutes including US dietary guidelines, activity goal of 30 minutes of physical activity 5 days/week; and discussion of the health benefits of weight loss along with general behavior change suggestions for weight loss. Best Practice: Receive standard lifestyle recommendations Quality-of-Life Assessment: Ancillary studies Questionnaire Administration: Ancillary studies
Effects of the Intervention on ADT-induced Changes in Homeostatic Model Assessment of Insulin Resistance (HOMA-IR)
4.5 percentage change
Standard Deviation 52.1
42.7 percentage change
Standard Deviation 28.1

PRIMARY outcome

Timeframe: 0 months, 6 months

Change in body weight from baseline.

Outcome measures

Outcome measures
Measure
Group I (Diet, Physical Activity)
n=7 Participants
Patients attend 10 in-person or virtual sessions with a registered dietician over 6 months to receive diet instructions. Patients also attend 2 one-on-one sessions with an exercise psychologist to receive instruction to complete aerobic physical activity and strength/resistance training. Patients may also complete up to 21 additional supervised exercise sessions. Dietary Intervention: Receive dietary instructions Exercise Intervention: Complete aerobic and strength/resistance exercises Quality-of-Life Assessment: Ancillary studies Questionnaire Administration: Ancillary studies
Group II (Standard Lifestyle Recommendations)
n=8 Participants
Patients receive standard lifestyle recommendations and attend an individual session with a dietitian over 20-30 minutes including US dietary guidelines, activity goal of 30 minutes of physical activity 5 days/week; and discussion of the health benefits of weight loss along with general behavior change suggestions for weight loss. Best Practice: Receive standard lifestyle recommendations Quality-of-Life Assessment: Ancillary studies Questionnaire Administration: Ancillary studies
Effects of the Intervention on ADT-induced Changes in Body Weight
-1.24 kg
Standard Deviation 2.6
1.01 kg
Standard Deviation 1.9

PRIMARY outcome

Timeframe: 0 months, 6 months

Change in waist circumference from baseline. Waist circumference was measured at 1" above umbilicus.

Outcome measures

Outcome measures
Measure
Group I (Diet, Physical Activity)
n=7 Participants
Patients attend 10 in-person or virtual sessions with a registered dietician over 6 months to receive diet instructions. Patients also attend 2 one-on-one sessions with an exercise psychologist to receive instruction to complete aerobic physical activity and strength/resistance training. Patients may also complete up to 21 additional supervised exercise sessions. Dietary Intervention: Receive dietary instructions Exercise Intervention: Complete aerobic and strength/resistance exercises Quality-of-Life Assessment: Ancillary studies Questionnaire Administration: Ancillary studies
Group II (Standard Lifestyle Recommendations)
n=8 Participants
Patients receive standard lifestyle recommendations and attend an individual session with a dietitian over 20-30 minutes including US dietary guidelines, activity goal of 30 minutes of physical activity 5 days/week; and discussion of the health benefits of weight loss along with general behavior change suggestions for weight loss. Best Practice: Receive standard lifestyle recommendations Quality-of-Life Assessment: Ancillary studies Questionnaire Administration: Ancillary studies
Effects of the Intervention on ADT-induced Changes in Waist Circumference
3.4 cm
Standard Deviation 1.5
1.8 cm
Standard Deviation 7.3

PRIMARY outcome

Timeframe: 0 months, 6 months

Change in lean mass from baseline. Lean mass was measured by Dual-Energy X-ray Absorptiometry (DEXA).

Outcome measures

Outcome measures
Measure
Group I (Diet, Physical Activity)
n=7 Participants
Patients attend 10 in-person or virtual sessions with a registered dietician over 6 months to receive diet instructions. Patients also attend 2 one-on-one sessions with an exercise psychologist to receive instruction to complete aerobic physical activity and strength/resistance training. Patients may also complete up to 21 additional supervised exercise sessions. Dietary Intervention: Receive dietary instructions Exercise Intervention: Complete aerobic and strength/resistance exercises Quality-of-Life Assessment: Ancillary studies Questionnaire Administration: Ancillary studies
Group II (Standard Lifestyle Recommendations)
n=8 Participants
Patients receive standard lifestyle recommendations and attend an individual session with a dietitian over 20-30 minutes including US dietary guidelines, activity goal of 30 minutes of physical activity 5 days/week; and discussion of the health benefits of weight loss along with general behavior change suggestions for weight loss. Best Practice: Receive standard lifestyle recommendations Quality-of-Life Assessment: Ancillary studies Questionnaire Administration: Ancillary studies
Effects of the Intervention on ADT-induced Changes in Lean Mass
-998 g
Standard Deviation 1604
-1129 g
Standard Deviation 1423

PRIMARY outcome

Timeframe: 0 months, 6 months

Change in fat mass from baseline. Fat mass was measured by Dual-Energy X-ray Absorptiometry (DEXA).

Outcome measures

Outcome measures
Measure
Group I (Diet, Physical Activity)
n=7 Participants
Patients attend 10 in-person or virtual sessions with a registered dietician over 6 months to receive diet instructions. Patients also attend 2 one-on-one sessions with an exercise psychologist to receive instruction to complete aerobic physical activity and strength/resistance training. Patients may also complete up to 21 additional supervised exercise sessions. Dietary Intervention: Receive dietary instructions Exercise Intervention: Complete aerobic and strength/resistance exercises Quality-of-Life Assessment: Ancillary studies Questionnaire Administration: Ancillary studies
Group II (Standard Lifestyle Recommendations)
n=8 Participants
Patients receive standard lifestyle recommendations and attend an individual session with a dietitian over 20-30 minutes including US dietary guidelines, activity goal of 30 minutes of physical activity 5 days/week; and discussion of the health benefits of weight loss along with general behavior change suggestions for weight loss. Best Practice: Receive standard lifestyle recommendations Quality-of-Life Assessment: Ancillary studies Questionnaire Administration: Ancillary studies
Effects of the Intervention on ADT-induced Changes in Fat Mass
1307 g
Standard Deviation 2984
2491 g
Standard Deviation 1189

Adverse Events

Group I (Diet, Physical Activity)

Serious events: 0 serious events
Other events: 5 other events
Deaths: 0 deaths

Group II (Standard Lifestyle Recommendations)

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

Serious adverse events

Adverse event data not reported

Other adverse events

Other adverse events
Measure
Group I (Diet, Physical Activity)
n=9 participants at risk
Patients attend 10 in-person or virtual sessions with a registered dietician over 6 months to receive diet instructions. Patients also attend 2 one-on-one sessions with an exercise psychologist to receive instruction to complete aerobic physical activity and strength/resistance training. Patients may also complete up to 21 additional supervised exercise sessions. Dietary Intervention: Receive dietary instructions Exercise Intervention: Complete aerobic and strength/resistance exercises Quality-of-Life Assessment: Ancillary studies Questionnaire Administration: Ancillary studies
Group II (Standard Lifestyle Recommendations)
n=11 participants at risk
Patients receive standard lifestyle recommendations and attend an individual session with a dietitian over 20-30 minutes including US dietary guidelines, activity goal of 30 minutes of physical activity 5 days/week; and discussion of the health benefits of weight loss along with general behavior change suggestions for weight loss. Best Practice: Receive standard lifestyle recommendations Quality-of-Life Assessment: Ancillary studies Questionnaire Administration: Ancillary studies
Musculoskeletal and connective tissue disorders
Knee Pain
11.1%
1/9 • Number of events 1 • up to 6 months
0.00%
0/11 • up to 6 months
General disorders
Fatigue
11.1%
1/9 • Number of events 1 • up to 6 months
0.00%
0/11 • up to 6 months
Musculoskeletal and connective tissue disorders
Hip and back pain
11.1%
1/9 • Number of events 1 • up to 6 months
0.00%
0/11 • up to 6 months
Hepatobiliary disorders
elevated liver function tests
11.1%
1/9 • Number of events 1 • up to 6 months
0.00%
0/11 • up to 6 months
Renal and urinary disorders
Urinary retention
11.1%
1/9 • Number of events 1 • up to 6 months
0.00%
0/11 • up to 6 months
Cardiac disorders
Presyncope
11.1%
1/9 • Number of events 1 • up to 6 months
0.00%
0/11 • up to 6 months

Additional Information

Marian L. Neuhouser, PhD

Fred Hutch Cancer Center

Phone: 206-667-4797

Results disclosure agreements

  • Principal investigator is a sponsor employee
  • Publication restrictions are in place